No Data
No Data
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. This growth would be primarily fueled by the expansion of ad
Some Investors May Be Willing To Look Past Harmony Biosciences Holdings' (NASDAQ:HRMY) Soft Earnings
Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) stock was strong despite it releasing a soft earnings report last week. However, we think the company is showing some signs that things are more pro
Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Harmony Biosciences Holdings First Quarter 2024 Earnings: EPS Beats Expectations
Harmony Biosciences Outperforms Expectations With Strong Q1 Results and Strategic Acquisition
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript